Saudi Medical Devices Market to grow at 5% CAGRBy: Shushmul Maheshwari
|
Saudi Medical Devices Market to grow at 5% CAGR
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
According to the report “Saudi Arabian Healthcare Market Forecast to 2012”, the medical devices market of Saudi Arab is the largest in the GCC region and is presently experiencing solid growth. The market closed at in excess of US$ 700 in 2008, and it is expected to grow at a robust growth in the coming future. One of the biggest drivers of this growth is the rapid growth of the country’s medical infrastructure. Between 2002 and 2008, more than 12,000 hospital beds have been added in the country. In addition, hundreds of pathology labs and clinics are being opened each year. This has created a huge demand for the installation and use of medical equipment and supplies.
Moreover, as per the report, the robust growth of the country’s population which will reach nearly 28 Million by 2012, coupled with the high prevalence of chronic diseases such as obesity, diabetes and cardiovascular diseases, will also push the demand for both therapeutic as well as well as monitoring devices. Diabetes, which presently affects more than 9% of the entire Saudi Arab adult population, is expected to create a huge demand for glucose monitoring and diagnostic devices.
The RNCOS analysis suggests that another 9,000 hospital beds are expected to be added in the country in near term, and the prevalence of chronic diseases is only expected to get worse. We expect that the total medical devices market - which includes medical equipments and supplies - will grow at a CAGR of over 5% through 2012.
“Saudi Arabian Healthcare Market Forecast to 2012” gives an extensive and objective analysis on the Saudi Arab Healthcare Market. The report has segmented the healthcare industry as the hospital services, pharmaceuticals and medical devices. Analysis as well as statistics on these segments regarding the market size, demand, supply, segmentation, key players etc has been presented in this report. An analysis on the future directions, supplemented with both facts and figures has also been done by the report. Thus the report serves as a useful guide for Healthcare companies, Government officials, consultants and investors etc who are planning to enter or evaluate the Saudi Arab Healthcare Market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM173.htm
Check DISCOUNTED REPORTS on http://www.rncos.comhttp://www.rncos.com/ |
|
| Keywords |
Saudi Arabian Healthcare Market Forecast to 2012, Saudi Arabian Healthcare Market, Healthcare Market of Saudi Arabia, Opportunities in Saudi Arabian Healthcare Market, Growth of Saudi Arabian Healthcare Market |
| Category |
Health and Fitness |
| Submission Date |
Apr 21, 2009 |
| Article Contact Name |
Shushmul Maheshwari || send email to Shushmul Maheshwari
|
|
Other links at Health and Fitness |
| 1. |
RNCOS Releases a New Report- Ukraine Pharma - New Opportunities for Growth
|
|
|
RNCOS has recently added a new Market Research Report titled, “Ukraine Pharma - New Opportunities for Growth” to its report gallery. According to the new research report, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical market grew by nearly 21% to register revenues in excess of US$ 2 Billion. The market is characterized by an increasing proportion of imported and high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine increased by nearly 20%, strongly pushing the value of pharmaceutical sales, despite a relatively ordinary growth in sales volume.
The future outlook of the industry also seems very positive as the market is expected to be driven by a number of reforms recently proposed by the government. Factors such as increasing penetration of health insurance and increasing disposable incomes of consumers will also fuel growth. The lack of effective price controls and high margins are also expected to lure foreign players in this market. The country’s unstable political environment, however, will be the biggest hurdle for investments. But overall, the market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012.
This report gives an extensive and objective analysis on the pharmaceutical market of Ukraine. It investigates both the past and present trends in the market, with its main focus on the future trends shaping the industry. The study discusses the performance of both the retail and hospital segments of the pharmaceutical market in detail and based on various present and future indicators, analyzes the future of these segments. This report gives valuable information to manufacturers/investors planning to enter the Ukrainian pharmaceutical market.
The Report Provides Forecasts on
- Macroeconomic Indicators
- Healthcare Indicators
- Population & Demographics
- Disease Profiles
- Total Pharmaceutical Market
- Retail Pharmaceutical Market
- Hospital Pharmaceutical Market
Key Player Profiling
“Ukraine Pharma - New Opportunities for Growth” provides brief profiling on key players, both domestic and foreign, currently operating in the Ukraine pharmaceutical market. This section describes the revenues and growth of players in the total pharmaceutical market, retail market and hospital market. Performance of key drugs in various segments of the market has also been evaluated. Business profiles of top five players, Berlin Chemie, Sanofi Aventis, Novartis, Arterium and Darnitsa, have also been discussed in this report.
For more information visit: http://rncos.com/Report/IM161.htm
Current Industry News: http://www.rncos.com/Blog/
|
| 2. |
US - Obesity Count Rising, Goldmine for Drug Makers
|
|
|
According to a RNCOS research report, “Booming Global Obesity Drug Market”, increasing prevalence of obesity and high unmet needs are driving the US to become one of the most potential markets for obesity drugs.
As per our analysis, the increasing rate of sedentary lifestyles and intake of high calorie food is taking its toll on the health of Americans. In 2007, around 207 Million people living in the US were classified as either overweight or obese. Out of these, more than 100 Million were found to be clinically obese. The figures of overweight and obesity are expected to reach 223 Million by 2012. The increasing prevalence of obesity in the country will in turn raise the prevalence of a number of lifestyle disorders such as diabetes, hypertension and dementia etc to catastrophic levels.
This pathetic condition is not only ringing alarm bells for the healthcare officials, but is also providing leveled field for obesity drug manufacturers. Americans spend around US$ 60 Billion annually on weight loss products. But no product available in the market has been able to provide the desired weight loss with an acceptable safety profile. Obesity drugs that are presently available in the market either suffer from serious side effects or just fail to provide the desired weight loss. More than 30 drugs, however, are undergoing various phase of clinical development wih three drugs in Phase-III development. Thus, any obesity drug if successfully launched in the market and if found to posses desired characteristics can lead to billions of dollars of revenues in no time, says the report.
“Booming Global Obesity Drug Market” is an extensive and objective analysis on the global market for obesity drugs. It investigates both the past and current trends in the global obesity market, and outlines the future trends shaping it up. It comprehensively assesses the performance of drugs, both on the market and in developing stage.
Based on various present and future indicators, the report evaluates future outlook and performance of key products in the industry. It can thus give valuable information for manufacturers/investors preparing to enter in the market for obesity drugs.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM166.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
|
| 3. |
RNCOS Releases a New Report - Malaysian Tourism Industry Forecast to 2012
|
|
|
RNCOS has recently added a new Market Research Report titled, “Malaysian Tourism Industry Forecast to 2012” to its report gallery. Malaysia is one of the most popular tourist destinations in the ASEAN region. Despite the global economic slowdown, it received around 22 Million international tourists in 2008, an increase of around 5% over the previous year (2007). Singapore, Indonesia and Thailand are important sources of visitors for the country.
According to our new research report “Malaysian Tourism Industry Forecast to 2012”, international tourist arrivals in Malaysia will grow at a CAGR of around 9% during 2009-2012, and tourism receipts from overseas tourists are expected to rise at a CAGR of around 10% to RM 70 Billion (US$ 19.6 Billion) in the same period. Apart from the ASEAN countries, tourist arrivals from China, India and the Middle East will strongly grow during the forecast period (2009-2012).
The Malaysian tourism industry will continue to grow rapidly in coming years on the back of increasing promotional activities by the government and growing reputation of the country as a shopping hub.
Our report provides an insight in the Malaysian tourism industry and studies its past, present and future scenario. It offers a detailed study of the forces driving the industry and discusses key factors making Malaysia a potential tourism destination. Our report also contains extensive information (analysis and statistical data) of various industrial parameters that help clients to analyze opportunities critical for their success in the Malaysian tourism industry.
With focus on various segments, including inbound tourism, outbound tourism, expenditure by inbound tourists, medical tourism, MICE and hotel industry, the report gives a thorough analysis of the tourism industry in Malaysia. Our report also includes industry forecast and estimates along with detailed information about key players operating in the Malaysian tourism industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM202.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
|
| 4. |
Detox Your Body the Right Way This Time
|
|
|
Drink water that you have purified at home throughout the day. The more that you drink, the more quickly the toxins that have built up over time will be removed. That's how to detox your body, the right way. Drink more purified water.
You'll see lots of different suggestions about how to detox your body. The internet is full of friendly advice, but the advice isn't always that good. Here are some healthy suggestions that will work to make you feel better and probably look better, too.
Environmental toxins are in the food that we eat, the clothes that we wear, the air that we breathe and the water that we drink. There are so many of them that our body's systems and organs become clogged with them.
The natural way to detoxify the digestive system, the kidneys, the liver and the cardiovascular system is to eat more plant-based foods that are high in fiber, and to drink more purified water. If at all possible, the foods should be organic. Organic foods are richer in nutrients. Certified organic farmers do not use pesticides, herbicides, artificial fertilizers or other toxins.
The purified water that you drink should be the most natural form that is available today. If you don't live on a farm in the mountains and own a spring that has been thoroughly tested for contaminants, the most natural form is home filtered.
When some people write about how to detox your body, they suggest de-mineralized or distilled water. But, those are unnatural forms. Your body was not designed to function on them.
Nearly everyone has heard of electrolytes and their importance in preventing dehydration. The most important electrolytes are sodium and potassium. Those are minerals.
Small amounts of sodium and potassium are present in every spring on earth. Other minerals, including calcium and magnesium may also be present. If you are trying to get close to a pristine state, you obviously don't want to drink something that is demineralized or distilled. It just doesn't seem to be a logical part of how to detox your body.
On the other hand, drinking water from a tap or from a bottle is not the right choice either. If you are on a public waterline, there will be chlorine and other cancer-causing chemicals flowing out of your tap.
If you drink from a plastic bottle, you are consuming the chemicals used to create the plastic. They also increase your cancer risk.
The thing to do is install a multi-stage selective filtration device. At the very least, you should have one on your kitchen tap and your bathroom's shower head. Toxins are absorbed through the skin and inhaled along with the steam from a hot shower.
Once you have installed these purifiers, here's how to detox your body: Drink eight ounces every morning when you get out of bed. Eat raw fruits, vegetables and nuts for breakfast. If you have access to organic free range eggs, eat those too. They are excellent sources of protein and essential fatty acids.
|
| 5. |
US Musckoloskeletal Device & Implant Market to Grow 11.8% by 2012
|
|
|
The US musckoloskeletal device and implant market was valued at more than US$ 20 Billion in 2008, making up for over 50% of the global market for such devices, according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, a new research report from RNCOS. The market is projected to see a blistering CAGR growth of 11.8% through 2012.
The reconstructive surgery segment, representing 33.5% of the musculoskeletal device and implant market, is expected to be the key booster to the US musculoskeletal device & implant market in the next four years, with Spinal (30.7%) and Fixation (16.0%) playing secondary role in the growth, anticipates the report.
Re-constructive joint implants are likely to continue to represent the largest segment in the reconstructive surgery field primarily due to rising demand for more procedures by increasing elderly population. The positive outlook for joint implants segment is based on figures of 2007 when nearly 663,000 knee replacement procedures and 251,000 hip replacement procedures were successfully performed, according to the report. Further, the number of both hip and knee replacement procedures is expected to surge sharply by 2012, with increasing incidents of knee and hip fractures and decreasing relevance of patients’ age profile. Patients are opting for such procedures at a much younger age now while earlier they were chosen at much older age.
“Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” discusses the past, current and future market scenario by providing factual details along with quality statistical data. The report gives insight into the structure, composition and working of the US healthcare sector and discusses hospital services, pharmaceuticals and medical devices available in the market.
Besides, it contains information on demand, market size and future prospects of all major US healthcare segments such as cardiovascular, in vitro diagnostics, diabetes, dental health, musculoskeletal, cosmetic surgery, oncology and wound care management. It will help the clients to understand key opportunities and challenges that will guide the market in future.
The research study provides forecast on factors like cancer surgery market, biotechnology-based cancer drug market, wound care product market, osteoporosis & low bone mass patients, hip replacement procedures, knee replacement procedures and cardiovascular diseases, and stroke expenditure by type.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM147.htm
Check DISCOUNTED REPORTS on http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
|
|
|
